Clinical trial
Phase I Clinical Trial of Recombinant Adenovirus Type 5 Therapeutic AIDS Vaccine Expressing Gag
NCT02762045 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Clinical Trial of Recombinant Adenovirus Type 5 Therapeutic AIDS Vaccine Expressing Gag
- Lead sponsor
- Centers for Disease Control and Prevention, China
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- December 31, 2017
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.